D441 Medical Dosage Calculations and Pharmacology - Set 5 - Part 2

Correct Answer: Decrease the infusion rate per orders

Option a is correct because vancomycin flushing syndrome is an infusion-related rate-dependent histamine release reaction managed by decreasing the infusion rate per provider orders, as it is not a true allergic anaphylactic response. Option b is incorrect because vancomycin flushing syndrome is not a true anaphylactic allergic reaction requiring epinephrine; it is a rate-dependent histamine release reaction that responds to slowing the infusion rate rather than requiring emergency treatment. Option c is incorrect because completely stopping the infusion and removing access is not the first-line intervention for vancomycin flushing syndrome; the medication can typically continue at a reduced rate while monitoring the patient for symptom resolution. Option d is incorrect because applying cold compresses addresses only surface comfort symptoms without treating the underlying cause of rate-dependent histamine release, and the priority intervention is adjusting the vancomycin infusion rate

Correct Answer: Avoid taking calcium or antacids with ciprofloxacin

Option d is correct because fluoroquinolones like ciprofloxacin must not be taken with calcium, iron, or antacids, as these substances chelate with the antibiotic and significantly reduce its absorption, rendering the medication therapeutically ineffective. Option a is incorrect because calcium directly interferes with ciprofloxacin absorption through chelation binding in the gastrointestinal tract, and taking them together would dramatically reduce the antibiotic's effectiveness rather than improving its absorption. Option b is incorrect because doubling the antibiotic dose is not an appropriate solution for drug-nutrient interactions, as it does not overcome the chelation-binding effect and could increase the risk of ciprofloxacin side effects including tendon rupture. Option c is incorrect because switching to a magnesium-based antacid would not resolve the interaction, since all metal-containing antacids including magnesium, aluminum, or calcium can chelate with fluoroquinolon

Correct Answer: Stop the medication and notify provider

Option b is correct because tendon pain is a warning sign of potential tendon rupture, a serious adverse effect of fluoroquinolones, and patients must immediately stop taking the medication and notify their provider at the first sign of tendon discomfort. Option a is incorrect because continuing the fluoroquinolone despite tendon pain increases the risk of complete tendon rupture, a serious and potentially debilitating adverse effect that requires immediate medication discontinuation rather than heat application and continuation. Option c is incorrect because simply reducing activity while continuing the medication does not address the underlying fluoroquinolone-induced tendon damage, and the priority intervention is stopping the medication immediately and seeking provider evaluation for symptoms. Option d is incorrect because adding an anti-inflammatory does not address the cause of the tendon pain, which is a serious drug adverse effect requiring immediate fluoroquinolone discontinua

Correct Answer: Ototoxicity from elevated drug levels

Option c is correct because tinnitus is a hallmark sign of ototoxicity from vancomycin, and the elevated trough level of eighteen micrograms per milliliter above the therapeutic range of ten to twelve confirms excessive drug accumulation causing inner ear damage. Option a is incorrect because while nephrotoxicity is a serious vancomycin adverse effect, the presenting symptom of tinnitus specifically indicates ototoxicity rather than kidney damage, which would more typically present with changes in urine output and creatinine elevation. Option b is incorrect because vancomycin flushing syndrome presents with facial and upper body flushing and itching during infusion, not as tinnitus developing gradually over days, making the infusion-related reaction an incorrect explanation for these symptoms. Option d is incorrect because peripheral neuropathy involves numbness, tingling, and pain in extremities, not tinnitus, and is not the primary adverse effect associated with elevated vancomycin t

Correct Answer: Withhold medication and contact provider

Option a is correct because trimethoprim-sulfamethoxazole contains a sulfonamide component, and a severe sulfa allergy with blistering rash suggesting Stevens-Johnson syndrome is a contraindication requiring the nurse to withhold the drug and contact the provider. Option b is incorrect because prophylactic antihistamine administration does not adequately protect against severe sulfa allergic reactions like Stevens-Johnson syndrome, and the medication is contraindicated in patients with known severe sulfa allergy requiring alternative antibiotic selection. Option c is incorrect because giving a test dose to a patient with a history of severe blistering sulfa allergy is dangerous and could trigger another serious reaction including Stevens-Johnson syndrome, which is potentially life-threatening and unpredictable in its severity. Option d is incorrect because proceeding with the full dose despite documented severe sulfa allergy violates patient safety principles, as the known sulfonamide

Correct Answer: Draw regular insulin first since it is clear

Option b is correct because when mixing insulins in one syringe, the clear regular insulin must always be drawn up first before the cloudy NPH insulin to prevent contamination of the regular insulin vial with NPH particles. Option a is incorrect because drawing cloudy NPH insulin first would risk contaminating the regular insulin vial with NPH suspension particles when inserting the needle, which could alter the rapid onset properties of the regular insulin supply. Option c is incorrect because the order of drawing insulins into a syringe is not interchangeable; the established nursing protocol specifically requires clear regular insulin before cloudy NPH insulin to maintain the integrity of the regular insulin vial. Option d is incorrect because mixing insulins in a separate vial is not standard practice; the correct technique involves drawing clear regular insulin first then cloudy NPH into the same syringe directly from their respective original manufacturer vials.

Correct Answer: Provide glucose tablets or simple carbohydrates

Option d is correct because for a conscious patient experiencing hypoglycemia who can safely swallow, the priority intervention is administering oral glucose tablets or simple carbohydrates to rapidly raise blood glucose levels before symptoms worsen. Option a is incorrect because intramuscular glucagon is reserved for unconscious patients or those unable to safely swallow oral glucose, and administering it to a conscious cooperative patient bypasses the simpler and more appropriate oral glucose intervention. Option b is incorrect because intravenous dextrose infusion is an escalated intervention typically reserved for unconscious patients or those who cannot take oral glucose safely, not the first-line treatment for a conscious hypoglycemic patient. Option c is incorrect because delaying treatment by ten minutes to recheck blood glucose while the patient is symptomatic with a dangerously low reading of forty-five could allow further neurological deterioration and loss of consciousness

Correct Answer: Stop metformin forty-eight hours before scan

Option a is correct because metformin must be discontinued forty-eight hours prior to procedures requiring contrast dye or NPO status, as the combination increases the risk of potentially fatal lactic acidosis from impaired renal drug clearance. Option b is incorrect because doubling the metformin dose on the day of a contrast dye procedure is dangerous and would significantly increase the risk of lactic acidosis, which is the primary serious toxicity concern when metformin interacts with contrast agents. Option c is incorrect because simply increasing fluid intake does not adequately mitigate the risk of lactic acidosis from metformin combined with contrast dye, and the established protocol requires complete medication discontinuation forty-eight hours before the procedure. Option d is incorrect because continuing metformin without modification before a contrast dye procedure violates safety guidelines, as the combination of metformin with iodinated contrast significantly increases th

Correct Answer: Rotation prevents lipodystrophy at injection sites

Option c is correct because repeatedly injecting insulin in the same location causes lipodystrophy, which involves fatty tissue changes including lipohypertrophy that alters insulin absorption and creates visible cosmetic deformities at the injection site. Option a is incorrect because the primary purpose of injection site rotation is not to increase absorption speed but to prevent lipodystrophy, and the abdomen is actually recommended for its consistent absorption rate regardless of which specific abdominal area is used. Option b is incorrect because injection site rotation is not primarily aimed at preventing allergic skin reactions, which are rare with modern insulin formulations; the main goal is preventing lipodystrophy from repeated trauma to the same subcutaneous tissue area. Option d is incorrect because insulin is administered subcutaneously into fatty tissue, not intramuscularly, and site rotation aims to prevent lipodystrophy rather than ensuring delivery to different muscle

Correct Answer: Take thirty minutes before a meal

Option b is correct because sulfonylureas like glipizide should be taken thirty minutes before a meal to allow the medication time to stimulate insulin release from the pancreas, which then coordinates with glucose absorption from the upcoming food intake. Option a is incorrect because taking glipizide at bedtime with a snack does not align with the medication's mechanism of stimulating insulin release before meals and could increase the risk of nocturnal hypoglycemia during sleeping hours without adequate monitoring. Option c is incorrect because taking glipizide two hours after eating misses the optimal timing window for coordinating insulin release with meal-related glucose absorption, significantly reducing the medication's therapeutic effectiveness for postprandial blood sugar control. Option d is incorrect because taking glipizide immediately after a meal rather than thirty minutes before delays the insulin release stimulation and fails to coordinate properly with the g

Correct Answer: Respiratory rate increases to sixteen breaths

Option a is correct because naloxone reverses opioid-induced respiratory depression, and a rising respiratory rate back toward normal range confirms the medication is effectively displacing morphine from opioid receptors and restoring adequate ventilation. Option b is incorrect because while naloxone reverses analgesia and the patient may experience pain, severe pain alone is a side effect of opioid reversal rather than the primary indicator the nurse uses to confirm effective respiratory depression reversal. Option c is incorrect because a significant blood pressure drop after naloxone administration would indicate an adverse response rather than effective reversal; naloxone typically causes hypertension and tachycardia as part of the opioid withdrawal response phenomenon. Option d is incorrect because deepening sedation after naloxone administration would indicate the reversal agent is not working and the patient continues to experience opioid-induced central nervous system depressio

Correct Answer: Increase dietary fiber and fluid intake

Option c is correct because opioids commonly cause constipation by decreasing gastrointestinal motility, and increasing dietary fiber and fluid intake helps maintain bowel regularity and prevent the serious complication of opioid-induced constipation. Option a is incorrect because decreasing water intake would worsen opioid-induced constipation by further hardening stool consistency, and adequate hydration is essential for promoting regular bowel movements while taking medications that slow gastrointestinal motility. Option b is incorrect because limiting physical movement would exacerbate constipation since immobility further reduces gastrointestinal motility, and gentle activity is actually recommended to help promote bowel function during opioid therapy for chronic pain conditions. Option d is incorrect because taking opioids on an empty stomach does not prevent constipation and may actually increase gastrointestinal side effects like nausea, while the constipation results from the

Correct Answer: Four grams daily acetaminophen liver threshold

Option b is correct because acetaminophen should not exceed four grams daily due to hepatotoxicity risk, and patients taking combination opioid-acetaminophen products who also use OTC acetaminophen often unknowingly surpass this critical safety limit. Option a is incorrect because the nurse's primary concern is not opioid receptor saturation but rather the cumulative acetaminophen dose from multiple sources exceeding the four-gram daily maximum that protects against potentially fatal liver damage. Option c is incorrect because the combination of prescription oxycodone-acetaminophen with additional acetaminophen does not cause seizures; the specific danger is cumulative acetaminophen hepatotoxicity from exceeding the established daily maximum safe dosage for liver metabolism. Option d is incorrect because renal elimination capacity is not the primary concern with excessive acetaminophen intake; the critical risk is hepatotoxicity and liver failure from overwhelming the liver's

Correct Answer: GI bleeding and possible ulcer perforation

Option d is correct because long-term NSAID use like ibuprofen significantly increases the risk of gastrointestinal bleeding, ulceration, and perforation, and dark tarry stools indicate upper GI bleeding requiring immediate medical evaluation and intervention. Option a is incorrect because acute pancreatitis from enzyme activation is not the primary gastrointestinal concern associated with prolonged NSAID use; the well-documented risk involves direct mucosal damage leading to gastric ulceration, bleeding, and possible perforation. Option b is incorrect because hepatic encephalopathy is associated with severe liver disease and ammonia accumulation, not chronic NSAID use, and the presenting sign of dark tarry stools specifically indicates gastrointestinal bleeding rather than hepatic complications. Option c is incorrect because intestinal obstruction from medication buildup is not a recognized complication of chronic NSAID therapy; the primary gastrointestinal risk involves prostaglandin

Correct Answer: Do not stop this medication abruptly

Option a is correct because gabapentin must be discontinued gradually through dose tapering to prevent withdrawal symptoms including seizures, and abrupt cessation of this anticonvulsant medication can trigger dangerous neurological rebound effects in patients. Option b is incorrect because grapefruit juice interaction is primarily associated with calcium channel blockers and statins, not gabapentin, and this instruction does not address the critical safety concern of preventing seizures from abrupt medication discontinuation. Option c is incorrect because gabapentin does not require fasting before administration, and avoiding meals is not a clinically significant precaution for this medication; the priority education point involves the serious risk of withdrawal seizures from sudden discontinuation. Option d is incorrect because drowsiness is a common expected side effect of gabapentin that typically improves with continued use, and discontinuing the medication due to drowsiness witho

Correct Answer: Potassium-rich foods like bananas and greens

Option a is correct because loop diuretics like furosemide cause significant potassium loss through increased urinary excretion, and patients must increase dietary potassium intake from foods like bananas, dark leafy greens, and potatoes to prevent hypokalemia. Option b is incorrect because increasing sodium intake would directly counteract the therapeutic purpose of furosemide, which promotes sodium and water excretion to reduce fluid overload in heart failure, and excess sodium would worsen edema and fluid retention. Option c is incorrect because while calcium is important for overall health, the primary electrolyte concern with loop diuretics is potassium depletion through renal excretion, not calcium loss, making potassium-rich food education the dietary priority for these patients. Option d is incorrect because iron supplementation is not the primary dietary concern for patients taking furosemide; the critical electrolyte risk involves hypokalemia from excessive potassium loss, wh

Correct Answer: Hyperkalemia from potassium retention

Option c is correct because spironolactone is a potassium-sparing diuretic that blocks aldosterone and retains potassium, and a serum level of five point eight with muscle weakness and palpitations indicates dangerous hyperkalemia requiring immediate intervention. Option a is incorrect because a potassium level of five point eight milliequivalents per liter significantly exceeds the normal range of three point five to five and represents a dangerous adverse effect rather than an expected or desirable therapeutic response to spironolactone. Option b is incorrect because spironolactone is a potassium-sparing diuretic that retains potassium rather than excreting it, making hypokalemia the opposite of the expected electrolyte disturbance, which is hyperkalemia from impaired potassium excretion mechanisms. Option d is incorrect because a potassium level of five point eight with cardiac and neuromuscular symptoms represents a clinically significant and dangerous hyperkalemic state, not a nor

Correct Answer: Take in the morning hours before bedtime

Option d is correct because diuretics like hydrochlorothiazide should be administered several hours before bedtime to prevent nocturia and sleep disruption from increased urinary frequency caused by the medication's diuretic effect during nighttime hours. Option a is incorrect because taking a diuretic at bedtime would cause significant nocturia and disrupted sleep from frequent nighttime urination, which negatively affects patient quality of life and medication adherence to the prescribed antihypertensive therapy regimen. Option b is incorrect because while food timing can affect some medications, the primary administration consideration for hydrochlorothiazide is avoiding nighttime dosing to prevent sleep disruption, and morning administration is preferred over midday for this specific reason. Option c is incorrect because timing significantly matters for diuretic medications, as taking them too close to bedtime causes disruptive nocturia that interferes with sleep quality and c

Correct Answer: Ototoxicity from rapid infusion rate

Option d is correct because furosemide infused too rapidly can cause ototoxicity presenting as tinnitus and hearing loss, which is why the medication must be infused at a rate not exceeding twenty milligrams per minute intravenously. Option a is incorrect because the sudden onset of tinnitus and hearing difficulty during intravenous furosemide administration indicates ototoxicity from rapid infusion, not hepatotoxicity, which would present with different symptoms like jaundice and elevated liver enzymes over time. Option b is incorrect because tinnitus and hearing loss during furosemide infusion are characteristic of rate-dependent ototoxicity, not an anaphylactic allergic reaction, which would present with respiratory distress, urticaria, and hypotension rather than auditory symptoms. Option c is incorrect because hearing loss and tinnitus are not expected normal therapeutic responses to furosemide diuretic therapy; they represent a serious ototoxic adverse effect specifically related

Correct Answer: Salt substitutes contain potassium causing hyperkalemia

Option a is correct because most salt substitutes contain potassium chloride instead of sodium chloride, and using them while taking the potassium-sparing diuretic spironolactone significantly increases the risk of developing dangerous life-threatening hyperkalemia. Option b is incorrect because salt substitutes do not reduce furosemide's diuretic effectiveness; the primary concern is their high potassium content combined with spironolactone's potassium-retaining effect, which together create a dangerous risk of hyperkalemia rather than drug ineffectiveness. Option c is incorrect because the concern with salt substitutes in this context is not sodium depletion but potassium excess, since these products replace sodium with potassium, compounding the hyperkalemia risk already elevated by spironolactone's potassium-sparing mechanism. Option d is incorrect because the salt substitute interaction is specifically concerning with spironolactone due to its potassium-sparing prop